Electrochemotherapy of cat soft tissue sarcomas
1997

Electrochemotherapy for Treating Soft Tissue Sarcomas in Cats

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): LM Mir, P Devauchelle, F Quintin-Colonna, F Delisle, S Doliger, D Fradelizi, J Belehradek Jr, S Orlowski

Primary Institution: Institut Gustave-Roussy

Hypothesis

Can electrochemotherapy effectively treat soft tissue sarcomas in cats that have relapsed after conventional therapies?

Conclusion

Electrochemotherapy significantly increased the lifespan of treated cats compared to untreated controls.

Supporting Evidence

  • Electrochemotherapy resulted in a mean survival time of 6.1 months for treated cats.
  • One partial regression of tumors was observed in the treated group.
  • Treated cats showed disease stabilization lasting from 2 weeks to 7 months.
  • Histological analysis revealed massive tumor cell death after treatment.

Takeaway

This study tested a new treatment for sick cats with tumors, and it helped them live longer without making them feel worse.

Methodology

The study involved administering bleomycin and electric pulses to treat soft tissue sarcomas in 12 cats, with follow-up observations on their health and tumor response.

Potential Biases

Potential bias due to non-randomized selection of treated and untreated groups.

Limitations

The study lacked rigorous randomization and included only cats with no proposed treatment options.

Participant Demographics

Cats with spontaneous large soft-tissue sarcomas, previously treated with conventional therapies.

Statistical Information

P-Value

P40.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication